SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Nilsson Peter) srt2:(1995-1999)"

Sökning: WFRF:(Nilsson Peter) > (1995-1999)

  • Resultat 1-10 av 110
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Nilsson, Peter, et al. (författare)
  • Effects of smoking cessation on insulin and cardiovascular risk factors--a controlled study of 4 months' duration
  • 1996
  • Ingår i: Journal of Internal Medicine. - : Wiley. - 1365-2796 .- 0954-6820. ; 240:4, s. 189-194
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVES: To investigate the effects on serum lipids, plasma fibrinogen, plasma insulin, plasma C-peptide and blood glucose, of smoking cessation after 4 months. To develop a group-based smoking intervention programme in primary health care. SETTING: Twenty health centres in primary health care in southern Sweden. SUBJECTS: Four hundred habitual smokers (> 10 cigarettes per day-1, > 10 years), recruited by advertisement in local papers. INTERVENTION: The smokers were randomized, after stratification for age and sex, to one intervention group (n = 200) and one control group (n = 200). The intervention group was offered supportive group sessions and free nicotine supplementation (patches, chewing gum). MAIN OUTCOME MEASURES: All participants were investigated at the start and after 4 months (medical history, physical examination, laboratory evaluation). Blood samples were drawn for determination of glucose, insulin and C-peptide, both in the fasting state and during an oral glucose tolerance test (OGTT), and for measurement of lipoproteins, fibrinogen, nicotine and cotinine. RESULTS: In the intervention group 98 of the subjects (48%) had quit smoking after 4 months. They were compared with the 156 subjects in the control group (91%) who were still daily smokers during the whole period. There were no significant differences in any variable between the two (total) experimental groups at baseline. Plasma nicotine and cotinine decreased (P < 0.001) in the intervention group following smoking cessation, and weight increased by 2.7 kg. In the intervention group HDL-cholesterol increased by 11% (P < 0.001), whereas HbA1c increased by 2% (P < 0.05) only in the control group. No changes occurred in levels of glucose, insulin, C-peptide and fibrinogen. CONCLUSION: The smoking cessation programme had a success rate of almost 50% over 4 months. Smoking cessation was associated with a marked increase in HDL-cholesterol levels but did not affect glucose tolerance. A concomitant weight increase may have blunted any independent beneficial effect of smoking cessation on glucose metabolism.
  •  
3.
  • Ekström, Ulf, et al. (författare)
  • An individual with a healthy phenotype in spite of a pathogenic LDL receptor mutation (C240F)
  • 1999
  • Ingår i: Clinical Genetics. - : Wiley. - 0009-9163. ; 55:5, s. 332-339
  • Tidskriftsartikel (refereegranskat)abstract
    • Familial hypercholesterolemia (FH) is caused by a defect in the function of the low density lipoprotein (LDL) receptor and inherited in an autosomal, codominant way. In this study we present a 13-year-old girl, compound heterozygote for the LDL receptor mutations C240F and Y167X. Fibroblasts from the patient showed very low cholesterol esterification rate, LDL uptake, and degradation compared to normal fibroblasts (< 2%, 8%, and < 2%, respectively). The C240F mutant was expressed in LDL receptor deficient CHOMldlA7 cells. Analysis of cell extracts by immunoblotting demonstrated delayed processing of the mutated LDL receptor, which was accumulated as a precursor protein of normal size. A high molecular weight form of the receptor was also detectable in these cells, which probably reflects cross-linking through the unpaired cysteine residue in the binding domain. Cells expressing the C240F mutant protein were unable to mediate uptake and degradation of LDL. The two siblings of the index case also carried the C240F mutation, but surprisingly one of them (a 17-year-old brother) showed no signs of hypercholesterolemia. This observation is consistent with the view that there may be cholesterol lowering mechanisms that can be activated, perhaps by mutations in known or hitherto unknown genes.
  •  
4.
  • Grimvall, E, et al. (författare)
  • Monitoring of polychlorinated biphenyls in human blood plasma: methodological developments and influence of age, lactation, and fish consumption
  • 1997
  • Ingår i: Archives of Environmental Contamination and Toxicology. - : Springer Science and Business Media LLC. - 0090-4341 .- 1432-0703. ; 32:3, s. 329-336
  • Tidskriftsartikel (refereegranskat)abstract
    • Human plasma samples from 50 wives of fishermen have been analyzed with respect to PCBs. The non-ortho-substituted PCB congeners CB-126 and CB-169 were determined by mass spectrometry in negative ion chemical ionization mode, which demonstrated a limit of detection of 30 fg. The recoveries of the internal standards used for determination of ortho-substituted CBs were approximately 95%. Two methods, one gravimetric and the other based on enzymatic determinations of triglycerides, cholesterol and phospholipids, were compared for the determination of total amount of lipids in the plasma samples; the correlation coefficient was 0.82 and the slope 0.98. For practical reasons, enzymatic determinations are recommended for further use. The total, lipid-adjusted concentrations of PCBs in plasma were influenced by age, total lactation time and consumption of fatty fish from the Baltic Sea.
  •  
5.
  • Jendeberg, L, et al. (författare)
  • Engineering of Fc(1) and Fc(3) from human immunoglobulin G to analyse subclass specificity for staphylococcal protein A.
  • 1997
  • Ingår i: JIM - Journal of Immunological Methods. - 0022-1759 .- 1872-7905. ; 201:1, s. 25-34
  • Tidskriftsartikel (refereegranskat)abstract
    • A system for production of recombinant Fc fragments of human IgG in Escherichia coli has been developed to allow for structural and functional studies of human Fc. The genes for the Fc fragments of human IgG subclasses 1 and 3, designated Fc(1) and Fc(3), were cloned from a human spleen cDNA library. The interactions to Staphylococcal protein A (SpA), a bacterial Fc receptor, that interacts with human IgG-Fc(1), but not with human IgG-Fc(3), were analyzed. To corroborate the involvement of amino acid residues in Fc, responsible for these differences in binding, two Fc variants were constructed; Fc(1(3)) and Fc(3(1)), each containing an isotypic dipeptide substitution. Production levels in E. coli of 1-10 mg/l of secreted Fc proteins, covalently linked as dimers, were routinely obtained. SpA-binding analyses of all four Fc variants using biosensor technology, showed that Fc(1) and Fc(3(1)) interact with SpA, while Fc(3) and Fc(1(3)) lack detectable SpA binding. The rendered SpA binding of the Fc variant Fc(3(1)), is concluded to result from the introduced dipeptide substitution (R435H, F436Y). The results demonstrate that the Fc expression system efficiently can be used in Fc engineering.
  •  
6.
  •  
7.
  • Nilsson, A, et al. (författare)
  • Transient hypertriglyceridemia of infancy
  • 1996
  • Ingår i: Acta Pædiatrica. - : Wiley. - 1651-2227 .- 0803-5253. ; 85:12, s. 1508-1510
  • Tidskriftsartikel (refereegranskat)abstract
    • A premature boy who had suffered from IRDS, bronchopulmonary dysplasia and retinopathy of prematurity developed massive hypertriglyceridemia (48.1 mmol/L) together with moderate hypercholesterolemia (12.6 mmol/L) at 5 months of age. Lipoprotein electrophoresis revealed a marked elevation of the level of the very low density lipoprotein fraction. There was a moderate decrease in the activity of a lipolytic enzyme, lipoprotein lipase (LPL). The child had neither liver or renal disorder nor any inflammatory disease. The hyperlipidemia disappeared spontaneously at the age of 3 years. The cause of the decreased LPL activity could not be established. A partial genetic deficiency in lipoprotein lipase appears the most likely explanation, since no signs of secondary lowering of LPL activity could be found.
  •  
8.
  •  
9.
  • Agardh, Carl-David, et al. (författare)
  • The effects of tolbutamide on lipoproteins, lipoprotein lipase and hormone-sensitive lipase
  • 1999
  • Ingår i: Diabetes Research and Clinical Practice. - 1872-8227. ; 46:2, s. 99-108
  • Tidskriftsartikel (refereegranskat)abstract
    • Type 2 diabetic patients are at increased risk to develop atherosclerotic vascular disease. These patients are often treated with sulphonylurea derivatives, and it has been suggested that this treatment might contribute to the increased atherosclerotic process. The aim of the present study was therefore to investigate whether tolbutamide influences lipid metabolism in such a way that the atherosclerotic process may be promoted. Addition of tolbutamide (5-500 mg/l) to isolated rat fat adipocytes inhibited the lipoprotein lipase (LPL) activity in a dose-dependent manner to levels about 50% of those registered in the absence of tolbutamide. This effect was due to inhibition of the activation of the enzyme in the tissue and not to interference with the interaction of enzyme with its substrate. Addition of tolbutamide (500 mg/l) also inhibited noradrenaline (100 nM) and isoprenaline (40 nM)-induced lipolysis by 48.1 +/- 7.4% (mean +/- S.E.M.) and 47.3 +/- 5.5%, respectively. The decreased lipolysis in tolbutamide preincubated adipocytes was shown to be the result of an inhibition of the phosphorylation of hormone sensitive lipase (HSL). Three months of tolbutamide treatment (0.5 g t.i.d.) in diet treated type 2 diabetic patients did not influence the plasma concentrations of cholesterol, triglycerides, LDL cholesterol, HDL cholesterol as well as HDL triglycerides and HDL phospholipids, and there were no differences compared to placebo treated patients. There was a tendency towards a decrement in the elimination rate of exogenous triglycerides in the tolbutamide group (P = 0.0801). No differences between the groups and no treatment effects were seen on LPL and hepatic lipase activities. In conclusion, our in vitro data show that tolbutamide has dual effects on lipid transport, with impairment of the LPL system, which would tend to decrease plasma lipoproteins by reducing hepatic production of lipoproteins. In vivo, these two effects seem to balance each other and plasma lipoprotein levels remain unaffected.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 110
Typ av publikation
tidskriftsartikel (67)
konferensbidrag (27)
rapport (5)
bok (4)
annan publikation (3)
doktorsavhandling (2)
visa fler...
bokkapitel (1)
recension (1)
visa färre...
Typ av innehåll
refereegranskat (90)
övrigt vetenskapligt/konstnärligt (17)
populärvet., debatt m.m. (3)
Författare/redaktör
Nilsson, Peter (45)
Nilsson-Ehle, Peter (29)
Olsson, Thomas (7)
Ekström, Ulf (7)
Abrahamson, Magnus (6)
Nygren, Per-Åke (6)
visa fler...
Uhlén, Mathias (5)
Andersen, Peter M., ... (5)
Öwall, Viktor (5)
Forsgren, Lars (5)
Johansson, Stefan (5)
Marklund, Stefan L. (5)
Nilsson, P. (4)
Hemani, Ahmed (4)
Larsson, A (4)
Arnadottir, Margret (4)
Berg, Anna-Lena (4)
Andréasson, Sten (3)
Ponjavic, Vesna (3)
Nilsson, Sten (3)
Lundeberg, Joakim (3)
Öberg, Johnny (3)
Persson, Björn (3)
Ehinger, Berndt (3)
Larsson, Rolf (2)
Karlsson, Anders (2)
Strang, Peter (2)
Andersson-Engels, St ... (2)
Vessby, Bengt (2)
Nilsson, M (2)
Hydén, Christer (2)
Thomsen, Peter, 1953 (2)
Nygren, Peter (2)
Hultberg, Björn (2)
Holmberg, Anders (2)
Nilsson, U (2)
Lindeberg, Staffan (2)
Strömberg, Ulf (2)
Lindberg, Gunnar (2)
Rylander, Lars (2)
Råstam, Lennart (2)
Keränen, M.-L. (2)
Arnadottir, M. (2)
Nilsson, Göran (2)
Carlsson, Jörgen (2)
Ståhl, Agneta (2)
Brundell-Freij, Kari ... (2)
Kumar, Shashi (2)
Velin, Hans (2)
Wretling, Peter (2)
visa färre...
Lärosäte
Lunds universitet (62)
Kungliga Tekniska Högskolan (11)
Uppsala universitet (10)
Umeå universitet (8)
Göteborgs universitet (6)
Linköpings universitet (6)
visa fler...
Karolinska Institutet (3)
Mittuniversitetet (2)
Chalmers tekniska högskola (2)
RISE (2)
VTI - Statens väg- och transportforskningsinstitut (2)
Högskolan Kristianstad (1)
Stockholms universitet (1)
Jönköping University (1)
visa färre...
Språk
Engelska (100)
Svenska (10)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (42)
Teknik (39)
Naturvetenskap (8)
Samhällsvetenskap (1)
Humaniora (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy